Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Br J Surg
    January 2026
  1. MCCLEMENTS J, Koh A, Lucocq J, Sellappan H, et al
    Adherence to Best Practice Guidelines for the Management of Intrahepatic Cholangiocarcinoma: Results from the Capbil Study.
    Br J Surg. 2026 Jan 23:znag001. doi: 10.1093.
    >> Share

    September 2025
  2. REESE T, Bjork D, Longva AMH, Kiim KS, et al
    Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases.
    Br J Surg. 2025;112:znaf198.
    >> Share

  3. HALLET J, Acher AW, Jivraj N, McIsaac DI, et al
    Association between anaesthetist hepatopancreatobiliary volume and outcomes.
    Br J Surg. 2025;112:znaf192.
    >> Share

    August 2025
  4. HUIBERS A, Wong A, Burgmans M, Ny L, et al
    Management of liver metastases from uveal melanoma.
    Br J Surg. 2025;112:znaf130.
    >> Share

    May 2025
  5. ACIDI B, Haddad A, Vauthey JN, Tran Cao HS, et al
    Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies.
    Br J Surg. 2025;112:znaf115.
    >> Share

    April 2025
  6. LOPEZ-LOPEZ V, Mohamed AH, Lopez-Conesa A, Fernandez D, et al
    Implementing laparoscopic liver surgery in Sub-Saharan Africa: a capacity-building and hepatopancreatobiliary mentorship model.
    Br J Surg. 2025;112:znaf107.
    >> Share

  7. BARTHOLOMA WC, Gilg S, Lundberg P, Larsen PN, et al
    Magnetic resonance-derived hepatic uptake index improves the identification of patients at risk of severe post-hepatectomy liver failure.
    Br J Surg. 2025;112:znaf103.
    >> Share

    March 2025
  8. KAWASHIMA J, Akabane M, Khalil M, Woldesenbet S, et al
    Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma.
    Br J Surg. 2025;112:znaf050.
    >> Share

  9. SOREIDE K
    Resection of multifocal intrahepatic cholangiocarcinoma.
    Br J Surg. 2025;112:znaf048.
    >> Share

  10. NING J, Dai C, Liu Q, Lin H, et al
    Application of the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) technique in conversion therapy for hepatocellular carcinoma.
    Br J Surg. 2025;112:znaf067.
    >> Share

  11. WANG X, Liang J, Cao L, Liu Y, et al
    Laparoscopic in situ anatomical resection of posterosuperior liver segments: preservation of segment 6 regardless of the presence of the inferior right hepatic vein.
    Br J Surg. 2025;112:znaf066.
    >> Share

  12. YAQUB S, Busund S, Smedman TM, Syversveen T, et al
    Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial.
    Br J Surg. 2025;112:znaf054.
    >> Share

    February 2025
  13. KAWAHARA W, Rivera B, Roberts J, Huang C, et al
    Laparoscopic left hemihepatectomy using the Arantius-first approach after 90Y transarterial radioembolization and immunotherapy in a cirrhotic patient.
    Br J Surg. 2025;112:znae305.
    >> Share

    October 2024
  14. GIANNONE F, Del Zompo F, Saviano A, Pencreach E, et al
    Impact of genetic alterations on long-term outcomes in resectable intrahepatic cholangiocarcinoma: meta-analysis.
    Br J Surg. 2024;111:znae257.
    >> Share

  15. PERRI G, Sparrelid E, Siriwardena AK, Marchegiani G, et al
    Estimation of intraoperative blood loss in hepatopancreatobiliary surgery: a Delphi consensus process of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA).
    Br J Surg. 2024;111:znae256.
    >> Share

    August 2024
  16. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    >> Share

  17. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    >> Share

  18. KITAHAMA T, Ashida R, Ohgi K, Yamada M, et al
    Laparoscopic right anterior inferior segmentectomy for hepatocellular carcinoma in a patient with congenital absence of the portal vein: intrahepatic artery-guided simulation.
    Br J Surg. 2024;111:znae210.
    >> Share

  19. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
    Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
    Br J Surg. 2024;111:znae181.
    >> Share

    July 2024
  20. BAHRI S, Brown L, Perin G, Balasubramanian SP, et al
    Comment on: Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae171.
    >> Share

  21. MARGONIS GA, Wang JJ, Boerner T, Moretto R, et al
    Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
    Br J Surg. 2024;111:znae176.
    >> Share

    May 2024
  22. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    >> Share

  23. JONES RP
    Lesional liver biopsies: better treatments, better studies, better science.
    Br J Surg. 2024;111:znae063.
    >> Share

  24. DE GRAAFF MR, Hendriks TE, Wouters M, Nielen M, et al
    Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
    Br J Surg. 2024;111:znae119.
    >> Share

    April 2024
  25. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Br J Surg. 2024;111:znae089.
    >> Share

  26. AKABANE M, Bekki Y, Imaoka Y, Inaba Y, et al
    Impact of donor characteristics on hepatocellular carcinoma recurrence after liver transplantation.
    Br J Surg. 2024;111:znae080.
    >> Share

  27. JOLIAT GR, de Man R, Rijckborst V, Cimino M, et al
    Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre study.
    Br J Surg. 2024;111:znae093.
    >> Share

  28. KORENBLIK R, Heil J, Smits J, James S, et al
    Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort.
    Br J Surg. 2024;111:znae087.
    >> Share

  29. SONG J, Cao L, Ma K, Li J, et al
    Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae099.
    >> Share

    March 2024
  30. PENG W, Wu Y, Zhang X, Li C, et al
    Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.
    Br J Surg. 2024;111:znae048.
    >> Share

  31. FAN ZQ, Serenari M, Lv X, Schwartz M, et al
    Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znae047.
    >> Share

  32. MAJLESARA A, Golriz M, Ramouz A, Khajeh E, et al
    Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgery.
    Br J Surg. 2024;111:znae053.
    >> Share

  33. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    >> Share

    January 2024
  34. BAUMGARTNER R, Engstrand J, Rajala P, Grip J, et al
    Comparing the accuracy of prediction models to detect clinically relevant post-hepatectomy liver failure early after major hepatectomy.
    Br J Surg. 2024;111:znad433.
    >> Share

  35. TZEDAKIS S, Yzhaky Shapira O, Schwarzinger M, Katsahian S, et al
    COVID-19 and excess mortality of patients with liver cancer in France, January 2020-September 2022.
    Br J Surg. 2024;111:znad359.
    >> Share

  36. ENDO Y, Pawlik TM
    Author response to: Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad423.
    >> Share

  37. MALIK AK, Figueiredo R, White SA
    Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad426.
    >> Share

    November 2023
  38. ARNTZ P, Olthof PB
    Assessment of liver function before major hepatectomy.
    Br J Surg. 2023;110:1588-1589.
    >> Share

    October 2023

  39. Corrigendum to: Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Oct 31:znad365. doi: 10.1093.
    >> Share

    September 2023
  40. PRIMAVESI F, Maglione M, Cipriani F, Denecke T, et al
    E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy.
    Br J Surg. 2023;110:1331-1347.
    >> Share

  41. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:1407.
    >> Share

  42. VOIGT KR, Wullaert L, de Graaff MR, Verhoef C, et al
    Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.
    Br J Surg. 2023;110:1284-1287.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016